期刊文献+

结核分枝杆菌EsxV/W融合蛋白对耻垢分枝杆菌表型及巨噬细胞功能的影响

Effects of Mycobacterium tuberculosis EsxV/W Fusion Protein on the Phenotype of Mycolicibacteriumsmegmatis and Macrophage Function
下载PDF
导出
摘要 目的:构建表达结核分枝杆菌EsxV/W融合蛋白的重组耻垢分枝杆菌(MS),分析重组MS的表型及对巨噬细胞功能的影响。方法:原核表达获取EsxV/W融合蛋白,纯化后免疫小鼠制备多克隆抗体;电击转化法构建重组菌株MS-EsxV/W及空载菌株MS-vec,使用制备的多克隆抗体检测融合蛋白在MS中的表达;分析表达EsxV/W融合蛋白的重组MS的菌落形态、生物膜及生长速率;菌落计数法检测重组MS在溶菌酶、孔雀绿、低pH、SDS、H2O2、NaNO2等不同环境条件下的存活能力,分析EsxV/W融合蛋白对MS表型的影响;重组MS侵染ANA-1巨噬细胞,Griess法检测ANA-1细胞NO的释放量,酶联免疫吸附实验检测ANA-1细胞肿瘤坏死因子-α(TNF-α)及白细胞介素-6(IL-6)的释放量,菌落计数法检测重组MS在ANA-1细胞内的存活能力。结果:成功构建能表达EsxV/W融合蛋白的重组菌株MS-EsxV/W,表达EsxV/W融合蛋白对MS的菌落形态、生物膜形成及生长速率无显著影响;表达EsxV/W融合蛋白不改变MS对溶菌酶、孔雀绿与低pH的耐受力,但可降低对SDS的耐受力,增强对H2O2与NaNO2的耐受力;侵染ANA-1细胞一定时间后,与MS-vec比较,MS-EsxV/W侵染的ANA-1细胞NO、TNF-α、IL-6释放量明显增加,且MS-EsxV/W的细胞内存活能力高于MS-vec。结论:EsxV/W融合蛋白可改变MS的表型并调控ANA-1巨噬细胞的免疫应答反应,有助于后续对esxV/W基因功能的探究。 Objective:To construct recombinant Mycolicibacterium smegmatis(MS) expressing Mycobacterium tuberculosis EsxV/Wfusion protein and analyze the phenotype of the recombinant MS and its effect on the macrophage function. Methods: The EsxV/Wfusion protein was obtained by prokaryotic expression, and polyclonal antibody was prepared by immunizing mice with purified EsxV/Wfusion protein. The recombinant strain MS-EsxV/W and the control strain MS-vec were constructed by electroporation, and theexpression of the fusion protein in MS was detected by using the generated polyclonal antibody. The colony morphology, biofilmformation, and growth rate of the recombinant MS expressing EsxV/W fusion protein were analyzed. The survival ability of therecombinant MS under different conditions, such as lysozyme, malachite green, low pH, SDS, H2O2 and NaNO2, was determined usingcolony counting method to assess the impact of EsxV/W fusion protein on the phenotype of MS. The recombinant MS was used to infectANA-1 macrophages. The release of NO from ANA-1 cells was detected by Griess method. Enzyme-linked immunosorbent assay wasperformed to measure the release of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) from ANA-1 cells, and the survivalability of the recombinant MS in ANA-1 cells was determined using colony counting method. Results:The recombinant strain MSEsxV/W expressing EsxV/W fusion protein, was successfully constructed. The expression of EsxV/W fusion protein had no significanteffect on the colony morphology, biofilm formation and growth rate of MS. The expression of EsxV/W fusion protein did not change thetolerance of MS to lysozyme, malachite green or low pH, but decreased the tolerance to SDS and increased the tolerance to H2O2 andNaNO2. After infecting ANA-1 cells for a certain period of time, the release of NO, TNF-α and IL-6 in ANA-1 cells infected by MSEsxV/W was significantly increased compared with MS-vec, and the intracellular survival ability of MS-EsxV/W was higher than thatof MS-vec. Conclusion:The EsxV/W fusion protein can change the phenotype of MS and regulate the immune response of ANA-1macrophages, which is conducive to the subsequent investigation of the function of esxV/W gene.
作者 余海燕 李玉洁 任芹 杨国平 Yu Haiyan;Li Yujie;Ren Qin;Yang Guoping(Pre-clinical College,Dali University,Dali,Yunnan 671000,China)
出处 《大理大学学报》 2024年第2期32-38,共7页 Journal of Dali University
基金 云南省地方本科高校基础研究联合专项资金项目(2017FH001-085) 大理大学高层次人才资助项目(KYBS201708)。
关键词 结核分枝杆菌 耻垢分枝杆菌 EsxV/W融合蛋白 ANA-1细胞 Mycobacterium tuberculosis Mycolicibacterium smegmatis EsxV/W fusion protein ANA-1 cells
  • 相关文献

参考文献1

二级参考文献10

  • 1Ponnighaus JM,Fine PE.The Karonga prevention trial—which BCG?[].Leprosy Review.1986
  • 2Black GF,Weir RE,Chaguluka SD,et al.Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy,non-mycobacterium bovis BCG vaccinated Malawian young adults[].Clinical and Diagnostic Laboratory Immunology.2003
  • 3Bennett AR,Gorak-Stolinska P,Ben-Smith A,et al.The PPD specific T-cell clonal response in UK and Malawian subjects following BCG vaccination:a new repertoire evolves over 12 months[].Vaccine.2006
  • 4McKinney JD,Jacobs WR,Bloom BR.Persisting problems in tuberculosis[].Emerging infections.1998
  • 5Jahn A,Floyd S,Crampin AC,et al.Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi[].The Lancet.2008
  • 6Munthali L,Mwaungulu JN,Munthali K,Bowie C,Crampin AC.Using tuberculosis suspects to identify patients eligible for antiretroviral treatment[].International Journal of Tuberculosis and Lung Disease.2006
  • 7Mwaungulu F,Crampin AC,Chagaluka S,et al.Antituberculous drug resistance in Karonga District:pattern and trend 1986—2001[].Malawi Med J.2002
  • 8Mwaungulu FB,Floyd S,Crampin AC,et al.Cotrimoxazole prophylaxis reduces mortality in human immunodefi ciency virus-positive tuberculosis patients in Karonga District, Malawi[].Bulletin of the World Health Organization.2004
  • 9Sterne JA,Fine PE,Ponnighaus JM,Sibanda F,Munthali M,Glynn JR.Does bacille Calmette-Guerin scar size have implications for protection against tuberculosis or leprosy?[].Tubercle and Lung Disease.1996
  • 10Ponnighaus JM,Fine PE,Bliss L,et al.The Karonga Prevention Trial:a leprosy and tuberculosis vaccine trial in northern Malawi.I.Methods of the vaccination phase[].Leprosy Review.1993

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部